Transfection of human monocyte-derived dendritic cells with CpG oligonucleotides

Immunology and Cell Biology

Volumn 83, Issue 3, 2005, Pages 278-285

  Erhardt, Michael ^a   Gorschlüter, Marcus ^a   Sager, Jens ^a   Ziske, Carsten ^a   Strehl, John ^a   Lilienfeld Toal, Marie V ^a   Schmidt Wolf, Ingo G H ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

CpG oligonucleotide; Cytokine induced killer cell; Dendritic cell; Electroporation; Lipofection

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; CD14 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CPG OLIGONUCLEOTIDE; FLUORESCEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 4; MEMBRANE ANTIGEN; MONOCYTE DERIVED DENDRITIC CELL VACCINE; ODN 2216; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; VACCINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER THERAPY; CELL COMPARTMENTALIZATION; CELL CULTURE; CONTROLLED STUDY; CPG ISLAND; CYTOKINE INDUCED KILLER CELL; CYTOKINE RELEASE; CYTOTOXICITY; DENDRITIC CELL; DRUG RESISTANCE; ELECTROPORATION; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; INTERNALIZATION; KILLER CELL; LIPOFECTION; MALIGNANT NEOPLASTIC DISEASE; MONOCYTE; MONOCYTE DERIVED DENDRITIC CELL; NONVIRAL GENE DELIVERY SYSTEM; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN LOCALIZATION; SUPERNATANT;

ANTIGENS, CD; CELL DIFFERENTIATION; CELL LINE, TUMOR; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; ELECTROPORATION; FATTY ACIDS, MONOUNSATURATED; FLOW CYTOMETRY; GROWTH SUBSTANCES; HLA-DR ANTIGENS; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-12; KILLER CELLS; LIPOPOLYSACCHARIDES; MONOCYTES; OLIGODEOXYRIBONUCLEOTIDES; QUATERNARY AMMONIUM COMPOUNDS; TRANSFECTION;

EID: 20444393469     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2005.01328.x     Document Type: Article

References (33)

1. Weiner GJ. The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides. J. Leukoc. Biol. 2000; 68: 455-63.
2. Pisetsky DS. Mechanisms of immune stimulation by bacterial DNA. Springer Semin. Immunopathol. 2000; 22: 21-33.
3. Weiner GJ, Liu HM, Wooldridge JE, Dahle CE, Krieg AM. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc. Natl Acad. Sci. USA 1997; 94: 10 833-7.
4. Wooldridge JE, Ballas Z, Krieg AM, Weiner GJ. Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma. Blood 1997; 89: 2994-8.
5. Whiteside TL, Odoux C. Dendritic cell biology and cancer therapy. Cancer Immunol. Immunother. 2004; 53: 240-48.
6. Ridgway D. The first 1000 dendritic cell vaccinees. Cancer Invest. 2003; 21: 873-86.
7. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 2002; 20: 709-60.
8. Schattenberg D, Schott M, Reindl G et al. Response of human monocyte-derived dendritic cells to immunostimulatory DNA. Eur. J. Immunol. 2000; 30: 2824-31.
9. Hartmann G, Weiner GJ, Krieg AM. CpGDNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl Acad. Sci. USA 1999; 96: 9305-310.
10. Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740-45.
11. Bauer S, Kirschning CJ, Hacker H et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl Acad. Sci. USA 2001; 98: 9237-42.
12. Spies B, Hochrein H, Vabulas M et al. Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice. J. Immunol. 2003; 171: 5908-912.
13. Trevani AS, Chorny A, Salamone G et al. Bacterial DNA activates human neutrophils by a CpG-independent pathway. Eur. J. Immunol. 2003; 33: 3164-74.
14. Verthelyi D, Zeuner RA. Differential signaling by CpG DNA in DCs and B cells: not just TLR9. Trends Immunol. 2003; 24: 519-22.
15. Manzel L, Macfarlane DE. Lack of immune stimulation by immobilized CpG-oligodeoxynucleotide. Antisense Nucleic Acid Drug Dev. 1999; 9: 459-64.
16. Martinet W, Schrijvers DM, Kockx MM. Nucleofection as an efficient nonviral transfection method for human monocytic cells. Biotechnol. Lett. 2003; 25: 1025-9.
17. Lu PH, Negrin RS. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo anti-tumor activity in mice with severe combined immunodeficiency. J. Immunol. 1994; 153: 1687-96.
18. Schmidt-Wolf IGH, Finke S, Trojaneck B et al. Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma. Br. J. Cancer 1999; 81: 1009-1016.
19. Leemhuis T, Wells S, Hom P, Scheffold C, Edinger M, Negrin RS. Autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin's disease. Blood 2000; 96: 839a.
20. Schmidt Wolf IGH, Lefterova P, Johnston V, Huhn D, Blume KG, Negrin RS. Propagation of large numbers of T cells with natural killer cell markers. Br. J. Haematol. 1994; 87: 453-8.
21. Macatonia SE, Hosken NA, Litton M et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J. Immunol. 1995; 154: 5071-9.
22. Rogge L, D'Ambrosio D, Biffi M et al. The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J. Immunol. 1998; 161: 6567-74.
23. Romani N, Gruner S, Brang D et al. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 1994; 180: 83-93.
24. Latz E, Schoenemeyer A, Visintin A et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 2004; 5: 190-98.
25. Krug A, Rothenfusser S, Hornung V et al. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 2001; 31: 2154-63.
26. Kerkmann M, Rothenfusser S, Hornung V et al. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J. Immunol. 2003; 170: 4465-74.
27. Hacker H, Mischak H, Miethke T et al. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 1998; 17: 6230-240.
28. Macfarlane DE, Manzel L. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. J. Immunol. 1998; 160: 1122-31.
29. Kadowaki N, Ho S, Antonenko S et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 2001; 194: 863-9.
30. Hornung V, Rothenfusser S, Britsch S et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 2002; 168: 4531-7.
31. Krug A, Towarowski A, Britsch S et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 2001; 31: 3026-37.
32. Bohle B, Jahn-Schmid B, Maurer D, Kraft D, Ebner C. Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18 and IFN-gamma production in cells from allergic individuals and inhibit IgE synthesis in vitro. Eur. J. Immunol. 1999; 29: 2344-53.
33. Liang X, Lu L, Chen Z et al. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival. Transplantation 2003; 76: 721-9.